| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 8,170 | 8,490 | 06.12. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Asker Healthcare Group AB: Acquisition of Cardio Dépôt | 59 | GlobeNewswire (Europe) | Asker Healthcare Group has acquired 100 per cent of the shares in Cardio Dépôt, a niche distributor of medical devices and consumables within cardiology in France.
"We are pleased to do our first... ► Artikel lesen | |
| 14.11. | Notice of Extraordinary General Meeting in Asker Healthcare Group AB (publ) | 9 | Cision News | ||
| 14.11. | Asker Healthcare Group AB: Interogo Holding announces intragroup transfer of its shares in Asker from Nalka Invest to its long-term equity strategy; and Nomination Committee proposes new board member | 145 | GlobeNewswire (Europe) | Today, Interogo Holding ("Interogo"), the parent company of Asker's main owner Nalka Invest, announced the intention to move its entire holding in Asker Healthcare Group to its long-term equity strategy.... ► Artikel lesen | |
| ASKER HEALTHCARE GROUP Aktie jetzt für 0€ handeln | |||||
| 06.11. | Asker Healthcare Q3 2025 slides: 25% earnings growth fueled by acquisitions | 1 | Investing.com | ||
| 06.11. | Asker Healthcare Group AB: Interim Report 1 January-30 September 2025 | 107 | GlobeNewswire (Europe) | Strong third quarter with earnings growth of 25 percent, of which 6 percent organic
1 July-30 September 2025
Net sales amounted to SEK 4,129m (3,597), up 15 percent.
Adjusted EBITA amounted to... ► Artikel lesen | |
| 03.11. | Asker Healthcare Acquires InnoMedicus; Expects To Contribute Positively To EBITA Margin | 1 | RTTNews | ||
| 03.11. | Asker Healthcare Group AB: Acquisition of InnoMedicus | 126 | GlobeNewswire (Europe) | Asker Healthcare Group has acquired 100 per cent of the shares in InnoMedicus AG, a niche distributor specialising in devices and solutions for precise diagnostics and minimally invasive therapies within... ► Artikel lesen | |
| 23.10. | ASKER HEALTHCARE GROUP AB: Invitation to Asker Healthcare Group's Q3 2025 webcast | 1 | Cision News | ||
| 02.10. | ASKER HEALTHCARE GROUP AB: Acquisition of Novus Med | 3 | Cision News | ||
| 29.09. | ASKER HEALTHCARE GROUP AB: Change of Nomination Committee members in Asker Healthcare Group ahead of the 2026 Annual General Meeting | 4 | Cision News | ||
| 23.09. | DNB CARNEGIE: RESULTS OF SALE OF SHARES IN ASKER HEALTHCARE GROUP AB | 4 | Cision News | ||
| 23.09. | DNB CARNEGIE: PROPOSED SALE OF SHARES IN ASKER HEALTHCARE GROUP AB | 1 | Cision News | ||
| 11.09. | ASKER HEALTHCARE GROUP AB: Asker Healthcare Group's Nomination Committee for the Annual General Meeting 2026 | 4 | Cision News | ||
| 29.08. | Asker Healthcare Group AB: Acquisition of Oudshoorn | 221 | GlobeNewswire (Europe) | Asker Healthcare Group has signed an agreement to acquire 100 per cent of the shares in Oudshoorn Chirurgische Techniek B.V. ("Oudshoorn"), a leading distributor of medical devices within orthopaedics... ► Artikel lesen | |
| 27.08. | Asker Healthcare Group AB: Bulletin from Extraordinary General Meeting in Asker Healthcare Group AB (publ) on 27 August 2025 | 128 | GlobeNewswire (Europe) | Asker Healthcare Group AB (publ) has held an Extraordinary General Meeting (EGM) today on 27 August 2025. The EGM was held at IVA Conference Centre in Stockholm, Sweden, with the option for shareholders... ► Artikel lesen | |
| 07.08. | Asker Healthcare Group AB: Acquisition of HNC | 265 | GlobeNewswire (Europe) | Asker Healthcare Group has acquired 100 per cent of the shares in Health Net Connections Limited ("HNC"), a leading provider of healthcare software for digital diagnostic imaging, ultrasound reporting... ► Artikel lesen | |
| 31.07. | Asker Healthcare Group AB: Acquisition of Finmed Group - first acquisition in France | 249 | GlobeNewswire (Europe) | Asker Healthcare Group has signed an agreement to acquire 80 per cent of the shares in Finmed SAS ("Finmed"), a leading provider of medical devices and solutions in France.
"Finmed is a highly trusted... ► Artikel lesen | |
| 22.07. | Asker Healthcare: Umsatzplus von 9 %, Aktie gibt dennoch nach | 7 | Investing.com Deutsch | ||
| 22.07. | Asker Healthcare Q1 2025: Akquisitionsstrategie treibt Umsatz um 16 % | 3 | Investing.com Deutsch | ||
| 22.07. | Asker Healthcare Q1 2025 slides: sales up 16% as acquisition strategy advances | 1 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,510 | +1,92 % | EQS-PVR: Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Siemens Healthineers AG
Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
01.12.2025 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,040 | +0,08 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,790 | +1,79 % | IPO Stock Of The Week: Health Care Leader BrightSpring Falls Back Into Buying Range | ||
| PROCEPT BIOROBOTICS | 35,860 | +1,21 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS | 47,720 | -0,60 % | Fresenius-Aktie: Kaufen! | Die Aktie des Gesundheitskonzerns Fresenius hat sich in den zurückliegenden Wochen doch wieder spürbar von den Mehrjahreshochs Ende Oktober entfernt. An den mittel- bis langfristigen Aussichten für... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,550 | +0,77 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| GENEDX | 158,96 | -1,85 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| PROGYNY | 24,020 | -0,54 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| BETA BIONICS | 29,380 | -2,07 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| NUTEX HEALTH | 160,95 | +2,65 % | Nutex Health extends share repurchase plan | ||
| GERRESHEIMER | 25,860 | -1,52 % | Gerresheimer vor Abstieg - Newcomer vor SDAX-Debüt? | Die nächste Indexüberprüfung am deutschen Aktienmarkt steht an. Die Entscheidung wird die Deutsche Börse heute nach Börsenschluss bekanntgeben. Nach mehreren Gewinnwarnungen und einem massiven Kursverfall... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 43,440 | +0,32 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,310 | +1,92 % | Aveanna Healthcare stock price target raised to $13 by Raymond James | ||
| GOODRX | 2,710 | -1,45 % | HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? | ||
| CERIBELL | 19,720 | +2,98 % | Ceribell Reports Third Quarter 2025 Financial Results | SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen |